Elucida Oncology
Executivos
Veja o organograma con seus 16 executivos principais
Biografias mais buscadas da Elucida Oncology
- Geno Germano, President, Chief Executive Officer and Director
- Ulrich Wiesner, Director
- Robert Essner, Chairman of the Board
Recentes movimentos de executivos em Elucida Oncology
- Ian Somaiya, Chief Financial Officer and Chief Business Officer, deixou a Companhia (Notícia publicada em 25 de agosto de 2023).
- Ramzi Benamar ingressará na Companhia como Chief Financial Officer em 1 de set. de 2023 (Notícia publicada em 25 de agosto de 2023).
Criar um alerta
para seguir os movimentos de executivos da Elucida Oncology.
Biotecnologia
Elucida Oncology possui 2.298 concorrentes concorrentes Lonza (Suíça), Eurofins (Luxemburgo) e Adaptive Phage Therapeutics (Estados Unidos).
Popular M&A news in Biotecnologia
- Genmab adquiriu ProfoundBio (publicado em 23 de maio de 2024).
- Centivo has announced the acquisition of Eden Health (publicado em 23 de maio de 2024).
- Johnson & Johnson has announced the acquisition of Proteologix (publicado em 20 de maio de 2024).
Outros contatos sugeridos na indústria do Biotecnologia
Notícias
Últimos comunicados de imprensa de Elucida Oncology
- Elucida Oncology to Present at the 42nd Annual J.P. Morgan Healthcare Conference :: Elucida Oncology, Inc.
- Elucida Oncology Presents Encouraging Clinical Data from Phase 1/2 Study of ELU001 in Solid Tumors Overexpressing Folate Receptor Alpha at ESMO Congress 2023 :: Elucida Oncology, Inc.
- Elucida Oncology Announces Abstract Accepted for Poster Presentation at ESMO Congress 2023 :: Elucida Oncology, Inc.
- Elucida Oncology Appoints Ramzi Benamar as Chief Financial Officer :: Elucida Oncology, Inc.
- Elucida Oncology Announces First Patient Dosed with ELU001 in Expansion Cohort of its Phase 1/2 Clinical Trial :: Elucida Oncology, Inc.
- Elucida Oncology Announces Positive Early Phase 1 Safety Data Along with Preclinical Data for the Treatment of Brain Metastases for ELU001, an Anti-Folate Receptor Alpha C’Dot Drug Conjugate :: Elucida Oncology, Inc.
- Elucida Oncology to Present New Clinical and Preclinical Data at the 2023 AACR Annual Meeting :: Elucida Oncology, Inc.
- Elucida Oncology to Present at the 41st Annual J.P. Morgan Healthcare Conference :: Elucida Oncology, Inc.
- Elucida Oncology to Present at the Piper Sandler 34th Annual Healthcare Conference :: Elucida Oncology, Inc.
- Elucida Oncology to Present at Two Upcoming Conferences :: Elucida Oncology, Inc.
- View more press releases Close
Redes sociais sobre Elucida Oncology
- Elucida Oncology na Wikipedia, Google News e Yahoo Finance
- Elucida Oncology na LinkedIn, Twitter e YouTube
Entrar em contato
Contate seus executivos por e-mail agora, incluindo Geno Germano 
Ligue para a Elucida Oncology em +1 646...
